Related references
Note: Only part of the references are listed.Clinical significance of coagulation factors in operable colorectal cancer
Suee Lee et al.
ONCOLOGY LETTERS (2017)
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
Michael Pimienta et al.
FRONTIERS IN PHYSIOLOGY (2017)
Making Meaningful Clinical Use of Biomarkers
Matthew J. Selleck et al.
BIOMARKER INSIGHTS (2017)
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Erika Larrea et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
Sabari Vallath et al.
SCIENTIFIC REPORTS (2016)
Analysis of Relationships Between Prethrombotic States and Cervical Cancer
You-Hong Sun et al.
Asian Pacific Journal of Cancer Prevention (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells
Hyun Ju Woo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis
Xiao-Wen Li et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2015)
Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
Hong Wang et al.
CLINICAL EPIGENETICS (2015)
The preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer
Koichi Fukumoto et al.
SURGERY TODAY (2015)
Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions
Dafna Groeneveld et al.
THROMBOSIS RESEARCH (2014)
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
Harriet Wikman et al.
ONCOTARGET (2014)
HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation
Pauline M. W. van Kempen et al.
CANCER MEDICINE (2014)
Coagulation and cancer: biological and clinical aspects
A. Falanga et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis (Review)
Yinghua Xu et al.
ONCOLOGY LETTERS (2013)
Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer
Jinfeng Zhang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2012)
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer
Yuka Takahashi et al.
BREAST CANCER (2012)
Cadm1 Is a Metastasis Susceptibility Gene That Suppresses Metastasis by Modifying Tumor Interaction with the Cell-Mediated Immunity
Farhoud Faraji et al.
PLOS GENETICS (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women
Renee M. Overmeer et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Epidemiology and pathophysiology of cancer-associated thrombosis
S. Noble et al.
BRITISH JOURNAL OF CANCER (2010)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts
Renee A. Douma et al.
BRITISH MEDICAL JOURNAL (2010)
Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation
Yoshimi Takai et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Metastasis: a therapeutic target for cancer
Patricia S. Steeg et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells
M. A. Kurer
MOLECULAR BIOLOGY REPORTS (2007)
Cancer and thrombosis: from molecular mechanisms to clinical presentations
H. R. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma
Hong Lok Lung et al.
CANCER RESEARCH (2006)
Loss of TSLC1 expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance
A Goto et al.
CANCER SCIENCE (2005)
TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia
RDM Steenbergen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model
E Dupuy et al.
JOURNAL OF HEPATOLOGY (2003)
TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer
M Kuramochi et al.
NATURE GENETICS (2001)
Share Paper
